GEMPHARMATECH CO., LTD. — Investor Relations & Filings
About GEMPHARMATECH CO., LTD.
GemPharmatech Co., Ltd. is a global biotechnology company specializing in the development and distribution of genetically engineered mouse models (GEMMs) for biomedical research. The company maintains one of the world's largest repositories of mouse strains, including knockout (KO), conditional knockout (cKO), and humanized models designed for oncology, immunology, and metabolic disease studies. Through its Knockout All Project, GemPharmatech aims to create KO and cKO strains for all protein-coding genes in the mouse genome. Beyond model production, the company provides comprehensive preclinical services such as efficacy testing, safety assessment, phenotyping, and customized gene editing using CRISPR/Cas9 technology. Serving pharmaceutical enterprises, biotechnology firms, and academic institutions, GemPharmatech supports drug discovery and fundamental life science research with high-throughput production capabilities and specialized germ-free mouse facilities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 上海君澜律师事务所关于江苏集萃药康生物科技股份有限公司调整2025年股票增值权激励计划及授予相关事项之法律意见书 | 2025-05-23 | Chinese | |
| 2025年股票增值权激励计划激励对象名单（截至授予日） | 2025-05-23 | Chinese | |
| 2022年限制性股票激励计划首次授予部分第二个归属期符合归属条件的公告 | 2025-05-23 | Chinese | |
| 上海荣正企业咨询服务（集团）股份有限公司关于江苏集萃药康生物科技股份有限公司2025年股票增值权激励计划授予事项之独立财务顾问报告 | 2025-05-23 | Chinese | |
| 关于作废部分已授予尚未归属的限制性股票的公告 | 2025-05-23 | Chinese | |
| 关于调整2022年限制性股票激励计划授予价格的公告 | 2025-05-23 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39536865 | 上海君澜律师事务所关于江苏集萃药康生物科技股份有限公司调整2025年股票增值权激励计划及授予相关事项之法律意见书 | 2025-05-23 | Chinese | ||
| 39536856 | 2025年股票增值权激励计划激励对象名单（截至授予日） | 2025-05-23 | Chinese | ||
| 39536842 | 2022年限制性股票激励计划首次授予部分第二个归属期符合归属条件的公告 | 2025-05-23 | Chinese | ||
| 39536831 | 上海荣正企业咨询服务（集团）股份有限公司关于江苏集萃药康生物科技股份有限公司2025年股票增值权激励计划授予事项之独立财务顾问报告 | 2025-05-23 | Chinese | ||
| 39536821 | 关于作废部分已授予尚未归属的限制性股票的公告 | 2025-05-23 | Chinese | ||
| 39536804 | 关于调整2022年限制性股票激励计划授予价格的公告 | 2025-05-23 | Chinese | ||
| 39536790 | 关于变更财务总监的公告 | 2025-05-23 | Chinese | ||
| 39536785 | 监事会关于公司2022年限制性股票激励计划首次授予部分第二个归属期归属名单的核查意见 | 2025-05-23 | Chinese | ||
| 39536779 | 关于向2025年股票增值权激励计划激励对象授予股票增值权的公告 | 2025-05-23 | Chinese | ||
| 39536768 | 华泰联合证券有限责任公司关于江苏集萃药康生物科技股份有限公司2024年度持续督导工作现场检查报告 | 2025-05-20 | Chinese | ||
| 39536758 | 华泰联合证券有限责任公司关于江苏集萃药康生物科技股份有限公司2024年度持续督导跟踪报告 | 2025-05-20 | Chinese | ||
| 39536743 | 药康生物2024年年度股东大会会议资料 | 2025-05-19 | Chinese | ||
| 39536735 | 关于召开2024年度暨2025年第一季度业绩暨现金分红说明会的公告 | 2025-05-19 | Chinese | ||
| 39536720 | 关于以集中竞价交易方式回购公司股份的进展公告 | 2025-05-06 | Chinese | ||
| 39536712 | 关于2025年度对子公司担保额度预计的公告 | 2025-04-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
GEMPHARMATECH CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58096/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58096 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58096 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58096 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58096}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GEMPHARMATECH CO., LTD. (id: 58096)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.